Genpharmasec Ltd. Reviews Board Performance in Separate Meeting of Independent Directors
Genpharmasec Ltd. announced that a Separate Meeting of Independent Directors was held on Tuesday, March 24, 2026. The meeting commenced at 11:00 AM and concluded at 11:30 AM.During the meeting, the Independent Directors reviewed the performance of Non-Independent Directors and the Board as a whole. They also evaluated the performance of the Chairperson, considering perspectives from Executive and Non-Executive Directors. Additionally, the quality, quantity, and timeliness of information flow between the company’s management and the Board of Directors were assessed, ensuring the Board's ability to effectively fulfill its duties.
Siddhesh Shende, Independent Director, digitally signed the communication. His Director Identification Number (DIN) is 09629926.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.